Dr. Andrew Lytle is a Clinical Instructor in the Department of Pathology and Laboratory Medicine at the University of British Columbia and a hematopathologist at BC Cancer. He completed his MD/PhD at Thomas Jefferson University, followed by residency in Anatomic Pathology at NYU Langone and fellowship training in Hematopathology at the Hospital of the University of Pennsylvania. His research focuses on lymphoma pathology, with current projects investigating follicular lymphoma epigenomics and the microenvironment of peripheral T-cell lymphomas.